Cite
HARVARD Citation
Paul, M. et al. (2018). Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet infectious diseases. 18 (4), pp. 391-400. [Online].